RETINEX

Serial Number 77090962
606

Registration Progress

Application Filed
Jan 25, 2007
Under Examination
Jun 16, 2009
Approved for Publication
Oct 1, 2008
Published for Opposition
Oct 21, 2008
Registered

Basic Information

Serial Number
77090962
Filing Date
January 25, 2007
Published for Opposition
October 21, 2008
Abandonment Date
July 16, 2012
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 16, 2012
Classes
005

Rights Holder

Ocucure Therapeutics, Inc.

03
Address
15 East Salem Ave., Suite 201
Roanoke, VA 24011

Ownership History

Ocucure Therapeutics, Inc.

Original Applicant
03
Roanoke, VA

Ocucure Therapeutics, Inc.

Owner at Publication
03
Roanoke, VA

Legal Representation

Attorney
Carole R. KLEIN

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description
Jul 16, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jul 16, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 7, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 6, 2011 EX5G S SOU EXTENSION 5 GRANTED
Dec 2, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 2, 2011 EXT5 S SOU EXTENSION 5 FILED
Jun 21, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2011 EX4G S SOU EXTENSION 4 GRANTED
Jun 16, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 16, 2011 EXT4 S SOU EXTENSION 4 FILED
Dec 17, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2010 EX3G S SOU EXTENSION 3 GRANTED
Dec 8, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 8, 2010 EXT3 S SOU EXTENSION 3 FILED
Jun 3, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 2, 2010 EX2G S SOU EXTENSION 2 GRANTED
Jun 1, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 1, 2010 EXT2 S SOU EXTENSION 2 FILED
Jan 27, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 27, 2010 EX1G S SOU EXTENSION 1 GRANTED
Dec 16, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 16, 2009 EXT1 S SOU EXTENSION 1 FILED
Jun 16, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2009 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 11, 2008 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 21, 2008 PUBO A PUBLISHED FOR OPPOSITION
Oct 1, 2008 NPUB O NOTICE OF PUBLICATION
Sep 12, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 2, 2008 ALIE A ASSIGNED TO LIE
Aug 29, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2008 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 29, 2008 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 3, 2008 ALIE A ASSIGNED TO LIE
May 3, 2008 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 3, 2007 CNSL R SUSPENSION LETTER WRITTEN
Nov 3, 2007 GNSL S LETTER OF SUSPENSION E-MAILED
Nov 3, 2007 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 26, 2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 26, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 26, 2007 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2007 CNRT R NON-FINAL ACTION WRITTEN
May 16, 2007 GNRT F NON-FINAL ACTION E-MAILED
May 14, 2007 DOCK D ASSIGNED TO EXAMINER
Jan 29, 2007 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
ocular pharmaceuticals
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005